The estimated Net Worth of Jon Leland Stern is at least $583 millier dollars as of 18 December 2020. Mr. Stern owns over 99,861 units of CohBar Inc stock worth over $289,825 and over the last 7 years he sold CWBR stock worth over $0. In addition, he makes $293,400 as Director at CohBar Inc.
Jon has made over 2 trades of the CohBar Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 99,861 units of CWBR stock worth $42,940 on 18 December 2020.
The largest trade he's ever made was buying 99,861 units of CohBar Inc stock on 18 December 2020 worth over $42,940. On average, Jon trades about 18,005 units every 19 days since 2018. As of 18 December 2020 he still owns at least 674,012 units of CohBar Inc stock.
You can see the complete history of Mr. Stern stock trades at the bottom of the page.
Jon Leland Stern serves as Director of the Company. Mr. Stern served in senior strategic roles with our Company from August 2012 until he was named our chief executive officer in October 2013. He was also appointed to our board of directors in May 2014. In March 2016, Mr. Stern assumed the role of chief operating officer. From 2009 to 2011, Mr. Stern was an active investor in information technology, media and real estate projects and companies. From 2006 to 2008, Mr. Stern served as executive vice president of Integrated China Media, a Guangzhou, China-based provider of digital entertainment content. From 2003 to 2008, Mr. Stern was a partner in Pacific Arts Group, a publisher of Chinese Contemporary Fine Art. Mr. Stern founded Digital Sparx in 1999, a distributor of digital entertainment content to movie-goers and served as president and chief executive officer of that company until 2002. In 1986 Mr. Stern founded Cine Coasters, Inc., a developer of sports stadium and movie theatre products, and served as its chief executive officer until its sale to a division of Liberty Media in 1998. Mr. Stern holds an MBA from the Marshall School of Business at the University of Southern California and a B.S. in Business Administration from The University of California, Berkeley. Our board of directors believes that Mr. Stern’s substantial experience as an entrepreneur and senior executive of growth stage companies as well as established businesses and his familiarity as an executive officer of our Company with the day-to-day operations of our business make him a valuable contributor to our board of directors.
As the Director of CohBar Inc, the total compensation of Jon Stern at CohBar Inc is $293,400. There are 7 executives at CohBar Inc getting paid more, with Steven Engle having the highest compensation of $2,410,850.
Jon Stern is 65, he's been the Director of CohBar Inc since 2020. There are 4 older and 8 younger executives at CohBar Inc. The oldest executive at CohBar Inc is Albion Fitzgerald, 71, who is the Independent Chairman of the Board.
Jon's mailing address filed with the SEC is C/O COHBAR, INC., 1455 ADAMS DRIVE, SUITE 2050, MENLO PARK, CA, 94025.
Over the last 7 years, insiders at CohBar Inc have traded over $0 worth of CohBar Inc stock and bought 586,523 units worth $136,480 . The most active insiders traders include Misha Petkevich, Kenneth C Cundy et Jon Leland Stern. On average, CohBar Inc executives and independent directors trade stock every 22 days with the average trade being worth of $9,727. The most recent stock trade was executed by David Greenwood on 1 November 2021, trading 20,000 units of CWBR stock currently worth $8,600.
cohbar (otcqx: cwbr and tsxv: cob.u) is the leader in the research and development of mitochondria-based therapeutics (mbts), an emerging class of drugs for the treatment of diseases associated with aging. mbts originate from the discovery of a novel group of peptides within the genome of mitochondria, the powerhouses of the cell. this groundbreaking discovery was made by our founders, world leaders in the biology of aging, metabolism and mitochondrial genomics. mbts offer the potential to address a broad range of diseases such as type 2 diabetes, cancer, atherosclerosis and neurodegenerative disorders.
CohBar Inc executives and other stock owners filed with the SEC include: